80.88
+0.79
+(0.99%)
At close: January 27 at 3:00:02 PM GMT+8
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CNY | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 4 | 7 |
| Avg. Estimate | 839M | 714M | 2.8B | 3.71B |
| Low Estimate | 839M | 714M | 2.79B | 3.58B |
| High Estimate | 839M | 714M | 2.81B | 3.95B |
| Year Ago Sales | -- | -- | 2.1B | 2.8B |
| Sales Growth (year/est) | -- | -- | 33.50% | 32.20% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 688278.SS | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
NKGNW NKGen Biotech, Inc.
0.1141
+14.10%
SABSW SAB Biotherapeutics, Inc.
0.0368
+15.00%
WXXWY WuXi Biologics (Cayman) Inc.
4.7800
+0.63%
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
MTVA MetaVia Inc.
1.8100
-8.12%
XBIO Xenetic Biosciences, Inc.
4.3100
+0.70%
IMTX Immatics N.V.
5.47
+1.30%
VTVT vTv Therapeutics Inc.
16.19
+10.21%
IMAB I-Mab
1.0200
-3.77%
INAB IN8bio, Inc.
0.2558
+3.19%